|
1
|
Ortiz A, Covic A, Fliser D, Fouque D,
Goldsmith D, Kanbay M, Mallamaci F, Massy ZA, Rossignol P,
Vanholder R, et al Board of the EURECA-m Working Group of ERA-EDTA:
Epidemiology, contributors to, and clinical trials of mortality
risk in chronic kidney failure. Lancet. 383:1831–1843. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stengel B: Chronic kidney disease and
cancer: A troubling connection. J Nephrol. 23:253–262.
2010.PubMed/NCBI
|
|
3
|
Hsu CY, Ordoñez JD, Chertow GM, Fan D,
McCulloch CE and Go AS: The risk of acute renal failure in patients
with chronic kidney disease. Kidney Int. 74:101–107. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kalantar-Zadeh K, Block G, Humphreys MH
and Kopple JD: Reverse epidemiology of cardiovascular risk factors
in maintenance dialysis patients. Kidney Int. 63:793–808. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ortiz A, Massy ZA, Fliser D, Lindholm B,
Wiecek A, Martínez-Castelao A, Covic A, Goldsmith D, Süleymanlar G,
London GM, et al: Clinical usefulness of novel prognostic
biomarkers in patients on hemodialysis. Nat Rev Nephrol. 8:141–150.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shidfar F, Ebrahimi SS, Hosseini S,
Heydari I, Shidfar S and Hajhassani G: The effects of Berberis
vulgaris fruit extract on serum lipoproteins, apoB, apoA-I,
homocysteine, glycemic control and total antioxidant capacity in
type 2 diabetic patients. Iran J Pharm Res. 11:643–652.
2012.PubMed/NCBI
|
|
7
|
Wang Y, Campbell T, Perry B, Beaurepaire C
and Qin L: Hypoglycemic and insulin-sensitizing effects of
berberine in high-fat diet- and streptozotocin-induced diabetic
rats. Metabolism. 60:298–305. 2011. View Article : Google Scholar
|
|
8
|
Zha W, Liang G, Xiao J, Studer EJ, Hylemon
PB, Pandak WM Jr, Wang G, Li X and Zhou H: Berberine inhibits HIV
protease inhibitor-induced inflammatory response by modulating ER
stress signaling pathways in murine macrophages. PLoS One.
5:e90692010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Katiyar SK, Meeran SM, Katiyar N and
Akhtar S: p53 cooperates berberine-induced growth inhibition and
apoptosis of non-small cell human lung cancer cells in vitro and
tumor xenograft growth in vivo. Mol Carcinog. 48:24–37. 2009.
View Article : Google Scholar
|
|
10
|
Jiang Q, Liu P, Wu X, Liu W, Shen X, Lan
T, Xu S, Peng J, Xie X and Huang H: Berberine attenuates
lipopolysaccharide-induced extracelluar matrix accumulation and
inflammation in rat mesangial cells: Involvement of NF-κB signaling
pathway. Mol Cell Endocrinol. 331:34–40. 2011. View Article : Google Scholar
|
|
11
|
Ichikawa H, Takada Y, Murakami A and
Aggarwal BB: Identification of a novel blocker of IκBα kinase that
enhances cellular apoptosis and inhibits cellular invasion through
suppression of NF-κB-regulated gene products. J Immunol.
174:7383–7392. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jackson-Bernitsas DG, Ichikawa H, Takada
Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM and Aggarwal BB:
Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates
constitutive NF-kappaB activation and proliferation in human head
and neck squamous cell carcinoma. Oncogene. 26:1385–1397. 2007.
View Article : Google Scholar
|
|
13
|
Korchnak AC, Zhan Y, Aguilar MT and Chadee
DN: Cytokine-induced activation of mixed lineage kinase 3 requires
TRAF2 and TRAF6. Cell Signal. 21:1620–1625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khan KA, Abbas W, Varin A, Kumar A, Di
Martino V, Dichamp I and Herbein G: HIV-1 Nef interacts with HCV
Core, recruits TRAF2, TRAF5 and TRAF6, and stimulates HIV-1
replication in macrophages. J Innate Immun. 5:639–656. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tada K, Okazaki T, Sakon S, Kobarai T,
Kurosawa K, Yamaoka S, Hashimoto H, Mak TW, Yagita H, Okumura K, et
al: Critical roles of TRAF2 and TRAF5 in tumor necrosis
factor-induced NF-κB activation and protection from cell death. J
Biol Chem. 276:36530–36534. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tao T, Cheng C, Ji Y, Xu G, Zhang J, Zhang
L and Shen A: Numbl inhibits glioma cell migration and invasion by
suppressing TRAF5-mediated NF-κB activation. Mol Biol Cell.
23:2635–2644. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ko YA, Mohtat D, Suzuki M, Park AS,
Izquierdo MC, Han SY, Kang HM, Si H, Hostetter T, Pullman JM, et
al: Cytosine methylation changes in enhancer regions of core
pro-fibrotic genes characterize kidney fibrosis development. Genome
Biol. 14:R1082013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang LN, Wang Y, Lu Y, Yin ZF, Zhang YH,
Aslanidi GV, Srivastava A, Ling CQ and Ling C: Pristimerin enhances
recombinant adeno-associated virus vector-mediated transgene
expression in human cell lines in vitro and murine hepatocytes in
vivo. J Integr Med. 12:20–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saha SK, Roy S and Khuda-Bukhsh AR:
Ultra-highly diluted plant extracts of Hydrastis canadensis and
Marsdenia condurango induce epigenetic modifications and alter gene
expression profiles in HeLa cells in vitro. J Integr Med.
13:400–411. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu D, Wen W, Qi CL, Zhao RX, Lü JH, Zhong
CY and Chen YY: Ameliorative effect of berberine on renal damage in
rats with diabetes induced by high-fat diet and streptozotocin.
Phytomedicine. 19:712–718. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen J, Qiao YQ, Ran ZH and Wang TR:
upregulation and pre-activation of TRAF3 and TRAF5 in inflammatory
bowel disease. Int J Med Sci. 10:156–163. 2013. View Article : Google Scholar :
|
|
22
|
Ruiz-Ballesteros E, Mollejo M, Rodriguez
A, Camacho FI, Algara P, Martinez N, Pollán M, Sanchez-Aguilera A,
Menarguez J, Campo E, et al: Splenic marginal zone lymphoma:
Proposal of new diagnostic and prognostic markers identified after
tissue and cDNA microarray analysis. Blood. 106:1831–1838. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Horie R and Watanabe T, Ito K, Morisita Y,
Watanabe M, Ishida T, Higashihara M, Kadin M and Watanabe T:
Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the
Hodgkin-Reed-Sternberg cells. Am J Pathol. 160:1647–1654. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Missiou A, Rudolf P, Stachon P, Wolf D,
Varo N, Aichele P, Colberg C, Hoppe N, Ernst S, Münkel C, et al:
TRAF5 deficiency accelerates atherogenesis in mice by increasing
inflammatory cell recruitment and foam cell formation. Circ Res.
107:757–766. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Su VY-F and Yang K-Y: Mesenchymal stem
cell-conditioned medium induces neutrophils apoptosis via
inhibition of NF-κB pathway and increases endogenous pulmonary stem
cells in endotoxin-induced acute lung injury. Eur Respir J.
46(Suppl 59): OA35202015.
|
|
26
|
Arora R, Yates C, Gary BD, McClellan S,
Tan M, Xi Y, Reed E, Piazza GA, Owen LB and Dean-Colomb W:
Panepoxydone targets NF-κB and FOXM1 to inhibit proliferation,
induce apoptosis and reverse epithelial to mesenchymal transition
in breast cancer. PLoS One. 9:e983702014. View Article : Google Scholar
|
|
27
|
Chen F, Wang M, O'Connor JP, He M,
Tripathi T and Harrison LE: Phosphorylation of PPARgamma via active
ERK1/2 leads to its physical association with p65 and inhibition of
NF-kappabeta. J Cell Biochem. 90:732–744. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Eschwege P1, Paradis V, Conti M, Loric S,
Dumas F, Berteau P, Ahmed M, Droupy S, Charpentier B, Legrand A, et
al: Bcl-2 and Bax expression on rat ischemic kidney. Transplant
Proc. 30:2861–2862. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saikumar P, Dong Z, Patel Y, Hall K,
Hopfer U, Weinberg JM and Venkatachalam MA: Role of hypoxia-induced
Bax translocation and cytochrome c release in reoxygenation injury.
Oncogene. 17:3401–3415. 1998. View Article : Google Scholar
|
|
30
|
Chien CT, Chang TC, Tsai CY, Shyue SK and
Lai MK: Adenovirus-mediated bcl-2 gene transfer inhibits renal
ischemia/reperfusion induced tubular oxidative stress and
apoptosis. Am J Transplant. 5:1194–1203. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ikezumi Y, Suzuki T, Karasawa T, Kawachi
H, Nikolic-Paterson DJ and Uchiyama M: Activated macrophages
downregulate podocyte nephrin and podocin expression via
stress-activated protein kinases. Biochem Biophys Res Commun.
376:706–711. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perysinaki GS, Moysiadis DK, Bertsias G,
Giannopoulou I, Kyriacou K, Nakopoulou L, Boumpas DT and Daphnis E:
Podocyte main slit diaphragm proteins, nephrin and podocin, are
affected at early stages of lupus nephritis and correlate with
disease histology. Lupus. 20:781–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ,
Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, et al: Berberine, a natural
plant product, activates AMP-activated protein kinase with
beneficial metabolic effects in diabetic and insulin-resistant
states. Diabetes. 55:2256–2264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Derosa G, Maffioli P and Cicero AF:
Berberine on metabolic and cardiovascular risk factors: An analysis
from preclinical evidences to clinical trials. Expert Opin Biol
Ther. 12:1113–1124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lan T, Shen X, Liu P, Liu W, Xu S, Xie X,
Jiang Q, Li W and Huang H: Berberine ameliorates renal injury in
diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P
signaling pathway. Arch Biochem Biophys. 502:112–120. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen L, Guo W, Zhang S, Lu W, Liao S and
Li Y: Berberine prevents high glucose-induced cell viability
inhibition and apoptosis in podocytes. Int J Clin Exp Med.
9:5942–5950. 2016.
|
|
37
|
Wan X, Chen X, Liu L, Zhao Y, Huang WJ,
Zhang Q, Miao GG, Chen W, Xie HG and Cao CC: Berberine ameliorates
chronic kidney injury caused by atherosclerotic renovascular
disease through the suppression of NFκB signaling pathway in rats.
PLoS One. 8:e597942013. View Article : Google Scholar
|
